Impact of concurrent medications on outcomes with PD1/PD-L1 inhibitors for metastatic urothelial carcinoma.

被引：10
|
作者：
Agarwal, Archana
Pond, Gregory Russell
Curran, Catherine
Nassar, Amin
Nuzzo, Pier Vitale
Kumar, Vivek
McGregor, Bradley Alexander
Wei, Xiao X.
Harshman, Lauren Christine
Choueiri, Toni K.
Kilbridge, Kerry L.
Sonpavde, Guru
机构：
[1] St Elizabeths Med Ctr, Dana Farber Canc Inst, Brighton, MA USA
[2] McMaster Univ, Hamilton, ON, Canada
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Lank Ctr Genitourinary Malignancy, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Dept Genitourinary Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.435
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
435
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of concurrent angiotensin inhibitors on outcomes with PD1/L1 inhibitors for patients (pts) with metastatic urothelial carcinoma (mUC).
    Agarwal, Archana
    Pond, Gregory Russell
    Curran, Catherine
    Nassar, Amin
    Nuzzo, Pier Vitale
    Kumar, Vivek
    McGregor, Bradley Alexander
    Wei, Xiao X.
    Harshman, Lauren Christine
    Choueiri, Toni K.
    Kilbridge, Kerry L.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] PD1/PD-L1 therapy in metastatic renal cell carcinoma
    Bruchbacher, Andreas
    Lemberger, Ursula
    Hassler, Melanie R.
    Fajkovic, Harun
    Schmidinger, Manuela
    CURRENT OPINION IN UROLOGY, 2020, 30 (04) : 534 - 541
  • [3] Research progress on PD-1 and PD-L1 inhibitors in the treatment of metastatic urothelial carcinoma
    Tang, Quanqing
    Li, Shihao
    Huang, Gaozhen
    Liu, Hongwei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [4] Impact of angiotensin blockade on response to PD1/L1 inhibitors for patients with metastatic urothelial carcinoma (mUC).
    Skelton, William Paul
    Jain, Rohit K.
    Curran, Catherine
    Pond, Gregory Russell
    Naqvi, Syeda Mahrukh Hussnain
    Kim, Youngchul
    Nuzzo, Pier Vitale
    Abou Alaiwi, Sarah
    Nassar, Amin
    Jain, Rakesh K.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [5] PD-1 and PD-L1 Inhibitors as Salvage Therapy for Urothelial Carcinoma
    Sonpavde, Guru
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11): : 1073 - 1074
  • [6] Real-world adoption of PD-L1 testing in metastatic urothelial carcinoma.
    Gupta, Shilpa
    Maculaitis, Martine C.
    Bernstein, Andrew
    Boudoures, Anna
    Tesic-Schnell, Marija
    Seal, Brian S.
    Mulvihill, Emily
    Doleh, Yunes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma
    Jain, Rohit K.
    Skelton IV, William Paul
    Pond, Gregory Russell
    Naqvi, Mahrukh
    Kim, Youngchul
    Curran, Catherine
    Freeman, Dory
    Nuzzo, Pier Vitale
    Abou Alaiwi, Sarah
    Nassar, Amin H.
    Jain, Rakesh K.
    Sonpavde, Guru
    CLINICAL GENITOURINARY CANCER, 2021, 19 (06) : 540 - 546
  • [8] First-line PD1/PD-L1 inhibitors for platinum-ineligible advanced urothelial carcinoma (UC).
    Agarwal, Archana
    Pond, Gregory Russell
    Drakaki, Alexandra
    Lee, Jae-Lyun
    Bilen, Mehmet Asim
    Di Lorenzo, Giuseppe
    Grivas, Petros
    Ornstein, Moshe Chaim
    Barata, Pedro C.
    Gupta, Shilpa
    Hussain, Syed A.
    Curran, Catherine
    Garcia, Jorge A.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [9] PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay
    Cimadamore, Alessia
    Massari, Francesco
    Santoni, Matteo
    Lopez-Beltran, Antonio
    Cheng, Liang
    Scarpelli, Marina
    Montironi, Rodolfo
    Moch, Holger
    CURRENT DRUG TARGETS, 2020, 21 (16) : 1664 - 1671
  • [10] Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
    Maiorano, Brigida Anna
    Di Maio, Massimo
    Cerbone, Linda
    Maiello, Evaristo
    Procopio, Giuseppe
    Roviello, Giandomenico
    JAMA NETWORK OPEN, 2024, 7 (03) : E241215
12345